Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1984 2
1985 2
1986 1
1987 4
1996 1
2000 1
2001 2
2002 4
2003 1
2004 2
2005 1
2006 3
2008 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy).
Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, Nozawa A, Shimoshige S, Eguchi M, Wakabayashi T, Yuda S, Hase M, Nakata T, Shimamoto K. Yoshioka T, et al. Among authors: kyuma m. Am Heart J. 2008 Mar;155(3):526.e1-7. doi: 10.1016/j.ahj.2007.10.042. Epub 2008 Jan 18. Am Heart J. 2008. PMID: 18294491
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Nakata T, Wakabayashi T, Kyuma M, Takahashi T, Tsuchihashi K, Shimamoto K. Nakata T, et al. Among authors: kyuma m. Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):186-94. doi: 10.1007/s00259-004-1624-8. Epub 2004 Sep 25. Eur J Nucl Med Mol Imaging. 2005. PMID: 15452671 Clinical Trial.
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, Shimoshige S, Uno K, Tsuchihashi K, Shimamoto K. Nagahara D, et al. Among authors: kyuma m. J Nucl Med. 2008 Feb;49(2):225-33. doi: 10.2967/jnumed.107.042564. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199625 Free article. Clinical Trial.
26 results